118 related articles for article (PubMed ID: 9812685)
1. [Preventive effects of tetrandrine on pulmonary hypertension and right ventricular hypertrophy in rats induced by monocrotaline].
Jin X; Zhang X; Xing J; Liu K; Wang H
Zhongguo Zhong Yao Za Zhi; 1996 Dec; 21(12):751-2, 763. PubMed ID: 9812685
[TBL] [Abstract][Full Text] [Related]
2. Tetrandrine inhibited chronic "inflammatory" pulmonary hypertension in rats.
Wang HL; Zhang XH; Jin X; Xing J; Zhang DR
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):401-4. PubMed ID: 10322926
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
4. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
6. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
7. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
8. [Effect of tetrandrine on pulmonary hypertension induced by monocrotaline in rats].
Zhang S; Sun B; Zhang J; Li F; Lei S; Cheng D; Yang X; Tan Y; Yao X; Li T
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):378-80. PubMed ID: 8732055
[TBL] [Abstract][Full Text] [Related]
9. Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Nagai R
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):17-32. PubMed ID: 8824928
[TBL] [Abstract][Full Text] [Related]
10. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H; Liu ZY; Guan Q
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
[TBL] [Abstract][Full Text] [Related]
11. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2004 Aug; 496(1-3):129-39. PubMed ID: 15288584
[TBL] [Abstract][Full Text] [Related]
12. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
Kato T; Nasu T; Sonoda H; Ito KM; Ikeda M; Ito K
J Cardiovasc Pharmacol; 2008 Jan; 51(1):18-23. PubMed ID: 18209564
[TBL] [Abstract][Full Text] [Related]
14. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
15. Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension.
Hirose K; Marui A; Arai Y; Kushibiki T; Kimura Y; Sakaguchi H; Yuang H; Chandra BI; Ikeda T; Amano S; Tabata Y; Komeda M
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1250-6. PubMed ID: 19026811
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of drag-reducing polymers in a rat model of monocrotaline-induced pulmonary hypertension.
Wang Y; Hu F; Mu X; Wu F; Yang D; Zheng G; Sun X; Gong K; Zhang Z
Biorheology; 2016 Jan; 53(1):13-22. PubMed ID: 26889655
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers in cirrhotic patients with portal hypertension.
Li D; Lu H; Li X; Quan Q; Li X; Lu W
Chin Med J (Engl); 1995 Nov; 108(11):803-8. PubMed ID: 8585970
[TBL] [Abstract][Full Text] [Related]
18. [Monocrotaline induce pulmonary hypertension in animal models].
Alexandru B; Bogdan MA
Pneumologia; 2001; 50(2):85-9. PubMed ID: 11584679
[TBL] [Abstract][Full Text] [Related]
19. Effect of endothelin antagonism on contractility, intracellular calcium regulation and calcium regulatory protein expression in right ventricular hypertrophy of the rat.
Stessel H; Brunner F
Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):37-45. PubMed ID: 14725613
[TBL] [Abstract][Full Text] [Related]
20. Monocrotaline induces interleukin-6 mRNA expression in rat lungs.
Bhargava A; Kumar A; Yuan N; Gewitz MH; Mathew R
Heart Dis; 1999; 1(3):126-32. PubMed ID: 11720614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
